Analysis of JC Virus Genotype Distribution and Transcriptional Control Region Rearrangements in Human Immunodeficiency Virus-Positive Progressive Multifocal Leukoencephalopathy Patients with and without Highly Active Antiretroviral Treatment

References

• Agostini HT, Ryschkewitsch CF, Mory R, Singer EJ, Stoner GL (1997). JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopa-thy and in urine from controls without PML: increased frequency of JCV type 2 in PML. J Infect Dis 176: 1–8.
   Google Scholar
• Agostini HT, Ryschkewitsch CF, Singer EJ, Baumhefner RW, Stoner GL (1998). JCV type 2B is found more frequently in brain tissue of progressive multifocal leukoencephalopathy patients than in the urine from controls. J Hum Virol 1: 200–206.
   PubMedGoogle Scholar
• Agostini HT, Ryschkewitsch CF, Stoner GL (1996). Genotype profile of human polyomavirus JC excreted in urine of i=unocompromised individuals. J Clin Microbiol 34: 159–164.
   PubMed Web of Science ®Google Scholar
• Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T, Eggers C, Stellbrink HJ (1998). Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12: 1149–1154.
   PubMed Web of Science ®Google Scholar
• Ault GS, Stoner GL (1993). Human poliomavirus JC pro-moter/enhancer rearrangements pattern from progres-sive multifocal leukoencephalophaty brain are unique derivates of a single archetypal structure. J Gen Virol 74: 1499–1507.
   PubMed Web of Science ®Google Scholar
• Berger JR, Kaszovitz B, Post MJ, Dickinson G (1987). Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. Ann In-tern Med 107: 78–87.
   Google Scholar
• Berger JR, Major EO (1999). Progressive multifocal leukoen-cephalopathy. Semin Neurol 19: 193–200.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Walker DL (1984). Progressive multifocal leukoencephalopathy. Neurol Clin 2: 299–313.
   PubMed Web of Science ®Google Scholar
• Chang D, Sugimoto, Wang M, Tsai RT, Yogo Y (1999). JC virus genotypes in a Taiwan aboriginal tribe (Bunun): implications for its population history. Arch Virol 144: 1081–1090.
   Google Scholar
• Chesters PM, Heritage J, McCance DJ (1983). Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 147: 676–684.
   PubMed Web of Science ®Google Scholar
• Cinque P, Casari S, Bertelli D (1998). Progressive multifocal leukoencephalopathy, HIV, and highly active antiretro-viral therapy. N Engl j Med 339: 848–849.
   Google Scholar
• Cinque P, Koralnik IG, Clifford DB (2003). The evolving face of HIV-related progressive multifocal leukoen-cephlaopathy: defining a consensus terminology. J NeuroVirol 9(s1): 88–92.
   Google Scholar
• Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, Mcarthur JC, Tyler KL, Tselis AC, Hyslop NE (1999). HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52: 623–625.
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola ML, A=assari A, Grisetti S, Paglia MG, Gentile M, Congolani A, Murri R, Liuzzi G, D'arminio Monforte A, Antinori A (2000). The ef-fect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoen-cephalopathy. J Infect Dis 182: 1077–1083.
   PubMed Web of Science ®Google Scholar
• Ferrante P, Mediati M, Caldarelli-Stefano R, Losciale L, Mancuso R, Cagni AE, Maserati R (2001). Increased frequency of JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients. Neuro Virology 7: 35–42.
   PubMed Web of Science ®Google Scholar
• Frisque RJ, Bream GL, Cannella MT (1984). Human poly-omavirus JC virus genome. J Virol 51: 458–469.
   PubMed Web of Science ®Google Scholar
• Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, Lazzarin A, Weber T, Cinque P (2000). Highly active antiretroviral therapy and pro-gressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replica-tion and immune response. Clin Infect Dis 30: 95–99.
   PubMed Web of Science ®Google Scholar
• Jensen PN, Major EO (1999). Viral variant nucleotide se-quences help expose leukocytic positioning in the JCvirus pathway to the CNS. J Leukoc Biol 65: 428–438.
   PubMedGoogle Scholar
• Jensen PN, Major EO (2001). A classification scheme for human polyomavirus JCV variants based on the nu-cleotide sequence of the noncoding regulatory region. J NeuroVirol 7: 280–287.
   PubMed Web of Science ®Google Scholar
• Miralles P, Berenguer J, Garcia de Viedman D, Padilla B, Cosin J, Lopez-Bemaldo de Quiros JC, Munoz L, Bouza E (1998). Treatment of AIDS-associated progressive multi-focal leukoencephalopathy with highly active antiretro-viral therapy. AIDS 12: 2467–2472.
   PubMed Web of Science ®Google Scholar
• Miralles P, Berenguer J, Lacruz C, Cosin J, Lopez C, Padilla B, Munoz L, Garcia de Viedma D (2001). Inflammatory reactions in progressive multifocal leukoencephalopa-thy after highly active antiretroviral therapy. AIDS 15: 1900–1902.
   Google Scholar